Search Results - "Yokoi, Tsuyoshi"

Refine Results
  1. 1

    The Emerging Role of Human Esterases by Fukami, Tatsuki, Yokoi, Tsuyoshi

    “…In this review, novel aspects of the role of esterases, which contribute to the metabolism of 10% of therapeutic drugs, are described. Esterases hydrolyze the…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Non-P450 Drug-Metabolizing Enzymes: Contribution to Drug Disposition, Toxicity, and Development by Fukami, Tatsuki, Yokoi, Tsuyoshi, Nakajima, Miki

    “…Most clinically used drugs are metabolized in the body via oxidation, reduction, or hydrolysis reactions, which are considered phase I reactions. Cytochrome…”
    Get full text
    Journal Article
  4. 4

    A comprehensive review of UDP-glucuronosyltransferase and esterases for drug development by Oda, Shingo, Fukami, Tatsuki, Yokoi, Tsuyoshi, Nakajima, Miki

    Published in Drug metabolism and pharmacokinetics (01-02-2015)
    “…UDP-glucuronosyltransferase (UGT) and esterases are recognized as the most important non-P450 enzymes because of their high contribution to drug metabolism…”
    Get full text
    Journal Article
  5. 5

    Role of cytochrome P450-mediated metabolism and involvement of reactive metabolite formations on antiepileptic drug-induced liver injuries by Sasaki, Eita, Yokoi, Tsuyoshi

    Published in Journal of toxicological sciences (01-01-2018)
    “…Several drugs have been withdrawn from the market or restricted to avoid unexpected adverse outcomes. Drug-induced liver injury (DILI) is a serious issue for…”
    Get full text
    Journal Article
  6. 6

    Identification of Specific MicroRNA Biomarkers in Early Stages of Hepatocellular Injury, Cholestasis, and Steatosis in Rats by Kagawa, Takumi, Shirai, Yuji, Oda, Shingo, Yokoi, Tsuyoshi

    Published in Toxicological sciences (01-11-2018)
    “…Abstract Recently, studies on circulating microRNAs (miRNAs) as potential biomarkers of drug-induced liver injury (DILI) have received increasing attention. It…”
    Get full text
    Journal Article
  7. 7

    Screening of specific inhibitors for human carboxylesterases or arylacetamide deacetylase by Shimizu, Mai, Fukami, Tatsuki, Nakajima, Miki, Yokoi, Tsuyoshi

    Published in Drug metabolism and disposition (01-07-2014)
    “…Esterases catalyze the hydrolysis of therapeutic drugs containing esters or amides in their structures. Human carboxylesterase (CES) and arylacetamide…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Recent progress in the use of microRNAs as biomarkers for drug-induced toxicities in contrast to traditional biomarkers: A comparative review by Oda, Shingo, Yokoi, Tsuyoshi

    Published in Drug metabolism and pharmacokinetics (01-04-2021)
    “…microRNAs (miRNAs) are small non-coding RNAs with 18–25 nucleotides. They play key regulatory roles in versatile biological process including development and…”
    Get full text
    Journal Article
  10. 10

    microRNAs as Mediators of Drug Toxicity by YOKOI, Tsuyoshi, NAKAJIMA, Miki

    “…microRNAs (miRNAs) represent the most abundant class of gene expression regulators that bind complementarily to transcripts to repress their translation or…”
    Get full text
    Journal Article
  11. 11

    Toxicological implications of modulation of gene expression by microRNAs by Yokoi, Tsuyoshi, Nakajima, Miki

    Published in Toxicological sciences (01-09-2011)
    “…MicroRNAs (miRNAs) are a large family of non-coding RNAs that are evolutionarily conserved, endogenous, and 21-23 nucleotides in length. miRNAs regulate gene…”
    Get full text
    Journal Article
  12. 12

    MicroRNA regulates human vitamin D receptor by Mohri, Takuya, Nakajima, Miki, Takagi, Shingo, Komagata, Sayaka, Yokoi, Tsuyoshi

    Published in International journal of cancer (15-09-2009)
    “…Most of the biological effects of 1α,25‐dihydroxyvitamin D3 (1,25(OH)2D3) are elicited by the binding to vitamin D receptor (VDR), which regulates gene…”
    Get full text
    Journal Article
  13. 13

    Expression of UGT1A and UGT2B mRNA in Human Normal Tissues and Various Cell Lines by NAKAMURA, Akiko, NAKAJIMA, Miki, YAMANAKA, Hiroyuki, FUJIWARA, Ryoichi, YOKOI, Tsuyoshi

    Published in Drug metabolism and disposition (01-08-2008)
    “…UDP-glucuronosyltransferases (UGTs) are major phase II drug metabolism enzymes that catalyze the glucuronidation of numerous endogenous and exogenous…”
    Get full text
    Journal Article
  14. 14

    Structure and Protein-Protein Interactions of Human UDP-Glucuronosyltransferases by Fujiwara, Ryoichi, Yokoi, Tsuyoshi, Nakajima, Miki

    Published in Frontiers in pharmacology (24-10-2016)
    “…Mammalian UDP-glucuronosyltransferases (UGTs) catalyze the transfer of glucuronic acid from UDP-glucuronic acid to various xenobiotics and endobiotics. Since…”
    Get full text
    Journal Article
  15. 15

    MicroRNA regulates the expression of human cytochrome P450 1B1 by TSUCHIYA, Yuki, NAKAJIMA, Miki, TAKAGI, Shingo, TANIYA, Takao, YOKOI, Tsuyoshi

    Published in Cancer research (Chicago, Ill.) (15-09-2006)
    “…MicroRNAs (miRNA) are small noncoding RNAs that regulate gene expression through translational repression or mRNA cleavage. Here, we found that cytochrome P450…”
    Get full text
    Journal Article
  16. 16

    Aberrant Activation of Cell-Cycle-Related Kinases and the Potential Therapeutic Impact of PLK1 or CHEK1 Inhibition in Uterine Leiomyosarcoma by Yoshida, Kosuke, Yokoi, Akira, Yamamoto, Tomofumi, Hayashi, Yusuke, Nakayama, Jun, Yokoi, Tsuyoshi, Yoshida, Hiroshi, Kato, Tomoyasu, Kajiyama, Hiroaki, Yamamoto, Yusuke

    Published in Clinical cancer research (13-05-2022)
    “…Uterine leiomyosarcoma is among the most aggressive gynecological malignancies. No effective treatment strategies have been established. This study aimed to…”
    Get full text
    Journal Article
  17. 17

    Expression of the chrXq27.3 miRNA cluster in recurrent ovarian clear cell carcinoma and its impact on cisplatin resistance by Yoshida, Kosuke, Yokoi, Akira, Sugiyama, Mai, Oda, Shingo, Kitami, Kazuhisa, Tamauchi, Satoshi, Ikeda, Yoshiki, Yoshikawa, Nobuhisa, Nishino, Kimihiro, Niimi, Kaoru, Suzuki, Shiro, Kikkawa, Fumitaka, Yokoi, Tsuyoshi, Kajiyama, Hiroaki

    Published in Oncogene (18-02-2021)
    “…Ovarian clear cell carcinoma (OCCC) is a histological subtype of epithelial ovarian cancer and exhibits dismal prognosis due to chemoresistance. Moreover, only…”
    Get full text
    Journal Article
  18. 18

    Pharmacological evidence for the involvement of ryanodine receptors in halothane-induced liver injury in mice by Jia, Ru, Oda, Shingo, Yokoi, Tsuyoshi

    Published in Toxicology (Amsterdam) (01-10-2020)
    “…Drug-induced liver injury (DILI) is a major safety concern in drug development. Halothane (HAL), an inhaled anesthetic, induces severe and idiosyncratic liver…”
    Get full text
    Journal Article
  19. 19

    Post-transcriptional Regulation of Human Pregnane X Receptor by Micro-RNA Affects the Expression of Cytochrome P450 3A4 by Takagi, Shingo, Nakajima, Miki, Mohri, Takuya, Yokoi, Tsuyoshi

    Published in The Journal of biological chemistry (11-04-2008)
    “…Pregnane X receptor (PXR) is a major transcription factor regulating the inducible expression of a variety of transporters and drug-metabolizing enzymes,…”
    Get full text
    Journal Article
  20. 20

    Cigarette smoking substantially alters plasma microRNA profiles in healthy subjects by Takahashi, Kei, Yokota, Shin-ichi, Tatsumi, Naoyuki, Fukami, Tatsuki, Yokoi, Tsuyoshi, Nakajima, Miki

    Published in Toxicology and applied pharmacology (01-10-2013)
    “…Circulating microRNAs (miRNAs) are receiving attention as potential biomarkers of various diseases, including cancers, chronic obstructive pulmonary disease,…”
    Get full text
    Journal Article